Skip to main content

CTOS 2025 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Freimut H. Schilling, MD (he/him/his)

Head of department Pediatric Oncology
Luzerner Kantonsspital (LUKS), Switzerland

Poster(s):

(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK